Your session is about to expire
← Back to Search
Behavioural Intervention
Wheelchair Exercise Training for Multiple Sclerosis
N/A
Recruiting
Led By Stephanie L Silveira, PhD
Research Sponsored by University of North Texas, Denton, TX
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 16-weeks
Awards & highlights
Study Summary
This trial studies the effectiveness of an exercise training program for wheelchair-users with MS, to see if it can improve metabolic health, MS symptoms and exercise behavior.
Who is the study for?
This trial is for adults over 18 with Multiple Sclerosis who are mostly wheelchair users and not currently active, meaning they don't do regular physical activity more than twice a week. They must have been relapse-free for the last month and will need a doctor's okay if there are health concerns that usually suggest exercise isn't safe.Check my eligibility
What is being tested?
The study tests a new exercise program called SPIN against a wellness program named WellMS in people with MS using wheelchairs. It looks at how well these programs work by checking participant numbers, satisfaction, safety, changes in metabolic health, MS symptoms, and whether participants stick to exercising after the 16-week course.See study design
What are the potential side effects?
Since this trial involves exercise programs rather than medication or medical procedures, side effects may include typical responses to new physical activities such as muscle soreness or fatigue. Any serious adverse events related to the exercises would be closely monitored.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 16-weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16-weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Study Feasibility: Incidence of Adverse Events
Study Feasibility: Number of Participants Recruited
Study Feasibility: Number of Participants Retained
Secondary outcome measures
Acceptability: Semi-structured interview
Acceptability: Survey
Other outcome measures
Adherence to assigned condition
Change in MS Symptoms: Depression
Change in MS Symptoms: Fatigue
+8 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Exercise Training InterventionExperimental Treatment1 Intervention
Group II: Wellness ControlActive Control1 Intervention
Find a Location
Who is running the clinical trial?
University of North Texas, Denton, TXLead Sponsor
9 Previous Clinical Trials
6,765 Total Patients Enrolled
2 Trials studying Multiple Sclerosis
33 Patients Enrolled for Multiple Sclerosis
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,965 Previous Clinical Trials
2,672,773 Total Patients Enrolled
18 Trials studying Multiple Sclerosis
1,784 Patients Enrolled for Multiple Sclerosis
Craig HospitalOTHER
40 Previous Clinical Trials
8,335 Total Patients Enrolled
2 Trials studying Multiple Sclerosis
178 Patients Enrolled for Multiple Sclerosis
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I passed a health screen for exercise or have doctor's clearance.I have been diagnosed with multiple sclerosis (MS).I use a wheelchair more than half of the time.I have not had a relapse in the last 30 days.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Exercise Training Intervention
- Group 2: Wellness Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Has this clinical research begun accepting participants?
"The clinicaltrials.gov platform suggests that this study is not recruiting any more patients, as the trial was initially posted on January 1st 2024 and last updated in August 4th 2023. However, there are presently 552 other trials across the globe actively enrolling participants."
Answered by AI
Share this study with friends
Copy Link
Messenger